EQ Labs enters into partnership with one of the world's largest private label tablet manufacturers

NewsGuard 100/100 Score

EQ Labs, Inc. (Pink Sheets: EQLB), a manufacturer and distributor of the EQ Smart Energy Drink®  effervescent tablets, announced today that it has entered into a partnership with one of the world's largest private label tablet manufacturers who has the capacity to produce one million EQ drink tablets per day. This relationship will result in reduced labor and transportation costs and quicker turnaround times for reorders placed by the Company's distributors and brokers.

"The Company has recently taken measures to enhance our operating efficiencies in order to meet the growing demand for our products, which now come in recyclable plastic tubes and individual biodegradable packets," Maurice "Mo" Owens, the CEO of EQ Labs stated.  "By entering into this  new manufacturing partnership, we'll be reducing the number of steps required in the manufacturing and distribution processes and should be able to increase our gross profit margin by 25%. Owens continued, "All of us believe this new operating model will enable us to step up our game and realize our goal of acquiring a competitive share of the energy drink market."

Source:

EQ Labs, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MD Anderson and CureVac collaborate on mRNA-based cancer vaccines